US 10736857
Treatment of pervasive developmental disorders with redox-active therapeutics
granted A61KA61K31/05A61K31/122
Quick answer
US patent 10736857 (Treatment of pervasive developmental disorders with redox-active therapeutics) held by PTC THERAPEUTICS, INC. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/05, A61K31/122, A61P, A61P25/00